Aalami and colleagues conducted a comprehensive systematic review and meta-analysis including 1,051 subjects, which demonstrated a pooled sensitivity of 70.1% and a specificity of 78.7% for urinary angiogenin, underscoring its diagnostic reliability and clinical applicability in bladder cancer detection through non-invasive methods. Here, ANG is linked to urinary bladder carcinoma.